Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2024-04-26 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2023年度财务决算报告
Annual Report Classification · 95% confidence The document is titled '2023 年度财务决算报告' which translates to '2023 Annual Financial Settlement Report'. It contains detailed financial data including balance sheet items, profit and loss statement, cash flow statement, and key financial ratios for the year 2023 compared to 2022. The content includes comprehensive financial performance and position information for the full fiscal year, typical of an annual report. The document length is 3349 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. There is no indication that this is a mere announcement or a certification letter. Therefore, it fits the definition of an Annual Report (10-K) type document, which covers company activity and full financial performance for the year. FY 2023
2024-04-26 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司2024 年第一季度报告" which translates to "Yangpu Medical Technology Co., Ltd. 2024 First Quarter Report." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and explanations of financial performance for the first quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial figures and analysis for the quarter, not just an announcement or summary. It also mentions that the report is unaudited, which is typical for quarterly reports. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-26 Chinese
关于2023年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 阳普医疗科技股份有限公司 regarding the 2023 annual asset impairment provisions. It details the amounts and methods of impairment provisions for various asset categories such as credit impairment, inventory, fixed assets, goodwill, intangible assets, and contract assets. The document includes accounting policy references and the impact on the company's consolidated profit. It also states that the impairment provisions have been audited and confirmed by an accounting firm. The document length is 3015 characters, which is relatively short and the content is focused on announcing the impairment provisions rather than presenting a full annual report or interim financial statements. It is not a full financial report but an announcement of a specific accounting action related to asset impairment. Therefore, it fits best under Regulatory Filings (RNS) as a regulatory announcement about accounting estimates and provisions, not a full audit report or annual report.
2024-04-26 Chinese
董事会审计委员会对会计师事务所2023年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee evaluating the performance of the external audit firm for the fiscal year 2023. It discusses the audit firm's qualifications, the audit procedures performed, communication with management, and the committee's supervision of the audit process. It references the 2023 annual report audit but does not contain the annual report itself or detailed financial statements. The document is relatively short (2311 characters) and serves as an audit oversight and evaluation report rather than the full audit report or annual report. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and related supervisory information, excluding full annual reports. Therefore, the correct classification is AR with high confidence. FY 2023
2024-04-26 Chinese
提名委员会实施细则2024.04
Governance Information Classification · 95% confidence The document is titled as the 'Nomination Committee Implementation Rules' of a company, detailing the structure, responsibilities, and procedures of the nomination committee within the board of directors. It focuses on governance practices, committee composition, decision-making processes, and related internal rules. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, or other report types. The content is about internal governance structure and committee rules, which fits the definition of Governance Information (CGR). The document length is 2135 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Therefore, the appropriate classification is Governance Information (CGR) with high confidence.
2024-04-26 Chinese
关于从珠海格金阳普大健康产业基金合伙企业（有限合伙）退伙的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 阳普医疗科技股份有限公司 regarding the company's withdrawal from a partnership in an investment fund (珠海格金阳普大健康产业基金合伙企业). It details the board and supervisory meetings approving the withdrawal, the background of the investment, the fund's structure, and the rationale for the withdrawal. The document includes no financial statements or detailed financial data but focuses on a corporate action related to investment and fund partnership changes. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about a corporate transaction involving a related party and fund withdrawal. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-04-26 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.